Back
HFA Premium Access

Digoxin lowers pulmonary artery pressures and heart rate in patients with heart failure and reduced ejection fraction

Session: Registries and clinical trials: new onset and chronic heart failure
Topic: Pharmacotherapy
Speaker: Professor J. Lindenfeld (Nashville, US)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Professor Joann Lindenfeld

Vanderbilt University, Nashville (United States of America)
20 presentations
3 followers

6 more presentations in this session

Discussant panel

Access
Like
Thumbnail

Primary results of TITRATE-HF: 1-year continuous GRMT implementation, prognosis, and LVEF improvement in de novo heart failure with reduced ejection fraction

Speaker: Professor J. Brugts (Rotterdam, NL)

Access
Slides
Video
Like
Thumbnail

Sudden cardiac arrest in patients with newly diagnosed NICM or MI/CAD - nationwide analysis of >19.000 patients with a WCD

Speaker: Professor J. Bauersachs (Hannover, DE)

Access
Slides
Video
Like
Thumbnail

Increased perirenal adipose tissue thickness is associated with autonomic dysfunction and reduced CGRP in patients with HFpEF: a prospective observational study

Speaker: Doctor O. Polat (Afyonkarahisar, TR)

Access
Slides
Video
Like
Thumbnail

Impact of M-TEER on health status in patients with moderate-to-severe functional mitral regurgitation and heart failure: results from RESHAPE-HF2

Speaker: Professor J. Butler (Dallas, US)

Access
Slides
Video
Like
Thumbnail

Access the full session

Registries and clinical trials: new onset and chronic heart failure

Speakers: Professor J. Lindenfeld, Professor J. Brugts, Professor J. Bauersachs, Doctor O. Polat, Professor J. Butler
Access
Video
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources